506 related articles for article (PubMed ID: 21117565)
1. Atypical diaphyseal femur fractures in patients with prolonged administration of bisphosphonate medication for osteoporosis.
Horning JA; Czajka J; Uhl RL
Orthopedics; 2010 Dec; 33(12):902. PubMed ID: 21117565
[No Abstract] [Full Text] [Related]
2. [Diphosphonate treatment of osteoporosis and risk of atypical femoral fractures].
Schwarz P
Ugeskr Laeger; 2012 Jan; 174(1-2):30. PubMed ID: 22233716
[No Abstract] [Full Text] [Related]
3. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
Black DM; Kelly MP; Genant HK; Palermo L; Eastell R; Bucci-Rechtweg C; Cauley J; Leung PC; Boonen S; Santora A; de Papp A; Bauer DC; ;
N Engl J Med; 2010 May; 362(19):1761-71. PubMed ID: 20335571
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-related atypical femoral fracture: Managing a rare but serious complication.
Silverman S; Kupperman E; Bukata S
Cleve Clin J Med; 2018 Nov; 85(11):885-893. PubMed ID: 30395525
[TBL] [Abstract][Full Text] [Related]
5. Going on a drug holiday?
Bonnick SL
J Clin Densitom; 2011; 14(4):377-83. PubMed ID: 22051091
[No Abstract] [Full Text] [Related]
6. Controversies in osteoporosis management: concerns about bisphosphonates and when are "drug holidays" required?
McClung M
Clin Obstet Gynecol; 2013 Dec; 56(4):743-8. PubMed ID: 24177063
[TBL] [Abstract][Full Text] [Related]
7. MANAGEMENT OF ENDOCRINE DISEASE: Atypical femoral fractures: risks and benefits of long-term treatment of osteoporosis with anti-resorptive therapy.
Adler RA
Eur J Endocrinol; 2018 Mar; 178(3):R81-R87. PubMed ID: 29339529
[TBL] [Abstract][Full Text] [Related]
8. What is the optimal duration of bisphosphonate therapy?
Ott SM
Cleve Clin J Med; 2011 Sep; 78(9):619-30. PubMed ID: 21885695
[TBL] [Abstract][Full Text] [Related]
9. Atraumatic bilateral femur fracture in long-term bisphosphonate use.
Yli-Kyyny TT; Tamminen I; Kröger H
Orthopedics; 2010 Dec; 33(12):867. PubMed ID: 21117559
[No Abstract] [Full Text] [Related]
10. Atypical femoral fractures and their relation to bisphosphonate use.
Tripto-Shkolnik L
Isr Med Assoc J; 2013 Aug; 15(8):447-50. PubMed ID: 24079069
[No Abstract] [Full Text] [Related]
11. [Femur fractures caused by long-term bisphosphonate therapy].
Somford MP; Thomassen BJ; Draijer WF
Ned Tijdschr Geneeskd; 2010; 154():A1218. PubMed ID: 20619008
[TBL] [Abstract][Full Text] [Related]
12. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
Black DM; Geiger EJ; Eastell R; Vittinghoff E; Li BH; Ryan DS; Dell RM; Adams AL
N Engl J Med; 2020 Aug; 383(8):743-753. PubMed ID: 32813950
[TBL] [Abstract][Full Text] [Related]
13. Fracture Risk During and After Bisphosphonate Drug Holidays: A Matter of Methods?
Adams AL
Med Care; 2020 May; 58(5):417-418. PubMed ID: 32149922
[No Abstract] [Full Text] [Related]
14. Bisphosphonates in the treatment of osteoporosis.
Diab DL; Watts NB
Endocrinol Metab Clin North Am; 2012 Sep; 41(3):487-506. PubMed ID: 22877426
[TBL] [Abstract][Full Text] [Related]
15. [Is SSBT associated with atypical femoral fracture? SSBT is associated with atypical femoral fracture - pathophysiology of atypical femoral fractures - ].
Mashiba T
Clin Calcium; 2012 Jun; 22(6):914-8. PubMed ID: 22653033
[TBL] [Abstract][Full Text] [Related]
16. Atypical femoral fracture.
Khan AA; Kaiser S
CMAJ; 2017 Apr; 189(14):E542. PubMed ID: 28396331
[No Abstract] [Full Text] [Related]
17. Bisphosphonate-associated femur fractures have high complication rates with operative fixation.
Prasarn ML; Ahn J; Helfet DL; Lane JM; Lorich DG
Clin Orthop Relat Res; 2012 Aug; 470(8):2295-301. PubMed ID: 22669553
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates and atypical femoral fractures: a time for reflection.
Compston JE
Maturitas; 2010 Jan; 65(1):3-4. PubMed ID: 19932574
[No Abstract] [Full Text] [Related]
19. Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals.
Thompson RN; Phillips JR; McCauley SH; Elliott JR; Moran CG
J Bone Joint Surg Br; 2012 Mar; 94(3):385-90. PubMed ID: 22371548
[TBL] [Abstract][Full Text] [Related]
20. Disentangling the emerging evidence around atypical fractures.
Abrahamsen B; Clark EM
Curr Rheumatol Rep; 2012 Jun; 14(3):212-6. PubMed ID: 22359230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]